Sunday, 05 December 2021

R-Tech Ueno loses case against Takeda

09 July 2012 | News | By BioSpectrum Bureau

R-Tech Ueno loses arbitration against Takeda

Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in the arbitration filed by R-Tech Ueno, together with Sucampo Pharmaceuticals and Sucampo AG, against Takeda Pharmaceutical. The arbitral award stipulated that the claims of R-Tech Ueno were not accepted and the supply agreement among R-Tech Ueno, Takeda and Sucampo executed in 2004 regarding the exclusive supply of AMITIZA capsules shall continue to be in effect. No damages were rendered.

R-Tech Ueno will continue to supply Amitiza capsules to Takeda based on the supply agreement. Although R-Tech Ueno has not announced its business forecast for the fiscal year ending March 2013, it will do after consideration of the arbitration result.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account